PLEASE CLICK HERE TO SUBMIT YOUR CONTACT INFORMATION NEW YORK and CHICAGO , Feb. 18, 2026 /PRNewswire/ — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf HaldensteinPLEASE CLICK HERE TO SUBMIT YOUR CONTACT INFORMATION NEW YORK and CHICAGO , Feb. 18, 2026 /PRNewswire/ — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein

Strategic Investment Solutions Inc. Data Breach Alert Issued By Wolf Haldenstein

2026/02/19 07:30
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

PLEASE CLICK HERE TO SUBMIT YOUR CONTACT INFORMATION

NEW YORK and CHICAGO , Feb. 18, 2026 /PRNewswire/ — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a preeminent national consumer rights law firm, is investigating claims on behalf of the individuals who have been impacted by the Strategic Investment Solutions Inc. (“SIS”) data breach.

SIS, located in Orland Park, Illinois, announced that personal information of individuals may have been stolen as part of a data breach which occurred in November 2025.

SIS is notifying affected people that their personal information, including at least names, Social Security numbers, and financial account information, may have been stolen.

If you have received a recent notice of the data breach and have experienced recent concerning activity, it is possible that your personal information was compromised and is being offered for sale on the dark web.

PLEASE CLICK HERE TO SUBMIT YOUR CONTACT INFORMATION

If you wish to discuss this data breach incident, or if you have any questions regarding your rights and interests in this matter, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at gstone@whafh.com, or visit our website.

Wolf Haldenstein Adler Freeman & Herz LLP has experience in the prosecution of consumer rights litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas and offices in New York, Chicago, Nashville and San Diego. Courts have repeatedly recognized the reputation and expertise of this firm and have appointed it to major positions in complex consolidated litigation.

Contact:

Gregory Stone, Director of Case and Financial Analysis
Carl Malmstrom, Esq., Of Counsel
Email: gstone@whafh.com or malmstrom@whafh.com
Tel: (800) 575-0735 or (212) 545-4774

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/strategic-investment-solutions-inc-data-breach-alert-issued-by-wolf-haldenstein-302691991.html

SOURCE Wolf Haldenstein Adler Freeman & Herz LLP

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09